Cargando…
Evaluation of the Impact of Intratumoral Heterogeneity of Esophageal Cancer on Pathological Diagnosis and P16 Methylation and the Representativity of Endoscopic Biopsy
BACKGROUND: P16 methylation is expected to be potential diagnostic and therapeutic targets for esophageal cancer (EC). The intratumoral heterogeneity (ITH) of EC has been mentioned but has not been quantitatively measured yet. We aimed to clarify the impact of ITH on pathological diagnosis and P16 m...
Autores principales: | Qin, Yu, Zhou, Jing, Fan, Zhiyuan, Gu, Jianhua, Li, Xinqing, Lin, Dongmei, Deng, Dajun, Wei, Wenqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416173/ https://www.ncbi.nlm.nih.gov/pubmed/34485122 http://dx.doi.org/10.3389/fonc.2021.683876 |
Ejemplares similares
-
Feasibility of using
P16
methylation as a cytologic marker for esophageal squamous cell carcinoma screening: A pilot study
por: Fan, Zhiyuan, et al.
Publicado: (2022) -
DNA methylation intratumor heterogeneity in localized lung adenocarcinomas
por: Quek, Kelly, et al.
Publicado: (2017) -
Microbial and epidemiological factors in early detection of esophageal squamous cell carcinoma and precancerous lesions
por: Li, Minjuan, et al.
Publicado: (2023) -
MET overexpression and intratumor heterogeneity in esophageal squamous cell carcinoma
por: Abboud, H.S., et al.
Publicado: (2021) -
Inter- and intratumor DNA methylation heterogeneity associated with lymph node metastasis and prognosis of esophageal squamous cell carcinoma
por: Teng, Huajing, et al.
Publicado: (2020)